Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients

NCT07221370 is registered in ClinicalTrials.gov with Riverside University Health System Medical Center as lead sponsor.

NCT NCT07221370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07221370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients
Lead sponsor
Riverside University Health System Medical Center
Phase
Phase 2/3
Overall status
Recruiting
Start date
October 21, 2024
Completion date
December 31, 2026
Enrollment
176 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile infection, vancomycin resistant enterococci infection